fashion -WSS

fashion

author：entertainment 2025-09-14 21:40:35 - browse：811

MODERNA - Norwood facility — Alex Hogan/STAT

Moderna announced Monday that, in a Phase 3 clinical trial, its combination Covid-19 and influenza vaccine generated stronger immune responses in older adults than individual vaccines that target those viruses.

The findings, disclosed in a press release, suggest the company may be on track to bring a combination flu and Covid vaccine to the market, potentially as early as autumn 2025.

“We’re excited to move forward in our discussions with regulators, and hopefully continue to help address respiratory viruses globally,” Moderna President Stephen Hoge told STAT in an interview in which he acknowledged that the fall 2025 vaccine rollout is a target the company would like to hit.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Hollywood unions extend contract negotiations for actors
Next article： Big Tobacco's 'harm reduction': Is it for real, or a sham?

leisure time

WSS

Cytokinetics CEO stresses company can launch heart drug on its own

Bird flu makes raw milk dangerous to consume, mouse study finds

Helping hospitals and community health centers plan for resilience

Wellcome Trust’s new CEO hopes Big Tech gets more involved in public health

The Readout: Lisata, Eisai x Biogen, and the Met Gala (!)

Solving academic medical centers' existential crisis

focus

fashion

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

entertainment

New air purifier tech could be key to improving indoor air quality

Second House panel advances two

How to save PrEP access — and even expand it

Addiction experts warn against a second 'war on drugs'

State Dept. review finds Biden bears some blame for Afghanistan failures

Readout Newsletter: Nvidia, Biogen, Ionis, AstraZeneca, ChatGPT

Sports medicine is finally prioritizing gender equality

NVIDIA and Google execs on the future of AI and drug discovery

After affirmative action ruling, medical educators look to 'holistic review'

Anxious about a speech? A startup wants you to pop a minty cardiac drug

hotspot

Asahi Kasei to buy Calliditas, picking up kidney disease drug

The HPV vaccine prevents cancer in men, too. Why do so few people get it?

Can we make enough H5N1 bird flu vaccine if there's a pandemic?

The Readout: Lisata, Eisai x Biogen, and the Met Gala (!)

Richard Slayman had a rejection episode of his pig kidney before leaving hospital

The HPV vaccine prevents cancer in men, too. Why do so few people get it?

leisure time

focus

leisure time

Wikipedia